TL;DR: Medium Biosciences is a Y Combinator Summer 2021 startup AI-designed Affinity Reagents, currently active with a team of 6.
AI-designed Affinity Reagents
Last verified:
We turn advances in AI and protein design into experimentally validated molecular tools, partnering with research teams and diagnostic developers to deliver high-performance affinity reagents in weeks, not months.
Built by LemStudio
Yes. Medium Biosciences was funded by Y Combinator in the Summer 2021 batch. AI-designed Affinity Reagents
We turn advances in AI and protein design into experimentally validated molecular tools, partnering with research teams and diagnostic developers to deliver high-performance affinity reagents in weeks, not months.
Medium Biosciences was part of Y Combinator's Summer 2021 batch.
Medium Biosciences has a team of 6 people according to Y Combinator's directory.
Medium Biosciences is currently listed as Active with a team of 6 in Y Combinator's directory.
Loading interactive view…